Komatsu, Y., Yoshino, T., Yamazaki, K., Yuki, S., Machida, N., Sasaki, T., . . . Ohtsu, A. (2013). Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer. Springer US.
Citação norma ChicagoKomatsu, Yoshito, et al. Phase 1 Study of Efatutazone, a Novel Oral Peroxisome Proliferator-activated Receptor Gamma Agonist, in Combination With FOLFIRI As Second-line Therapy in Patients With Metastatic Colorectal Cancer. Springer US, 2013.
Citação norma MLAKomatsu, Yoshito, et al. Phase 1 Study of Efatutazone, a Novel Oral Peroxisome Proliferator-activated Receptor Gamma Agonist, in Combination With FOLFIRI As Second-line Therapy in Patients With Metastatic Colorectal Cancer. Springer US, 2013.